Monitoring new oral antithrombotics: what we should know before we can decide

被引:5
|
作者
Al dieri, R. [1 ]
Hemker, H. C. [1 ]
机构
[1] Cardiovasc Res Inst Maastricht, Synapse BV, NL-6200 MD Maastricht, Netherlands
关键词
DIRECT THROMBIN INHIBITOR; HEALTHY MALE-SUBJECTS; POPULATION PHARMACOKINETICS; LABORATORY MONITORING; VENOUS THROMBOEMBOLISM; PHARMACODYNAMICS; GENERATION; HEPARIN; XIMELAGATRAN; HYPERCOAGULABILITY;
D O I
10.1111/j.1538-7836.2010.04057.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2833 / 2835
页数:4
相关论文
共 50 条